Factors That Could Impact on Liver Fibrosis Staging by Transient Elastography
- PMID: 26770833
- PMCID: PMC4684863
- DOI: 10.1155/2015/624596
Factors That Could Impact on Liver Fibrosis Staging by Transient Elastography
Abstract
Transient elastography (TE) based on liver stiffness measurement (LSM) is one of the most validated noninvasive methods for liver fibrosis staging in patients with chronic liver diseases. This method is painless, has no potential complications, is rapid (<10 min), and can be performed at the patient's bedside. However, several points should be considered when interpreting TE results. This review aims to discuss the critical points that might influence liver stiffness and TE results. Spectrum bias and the impact of the prevalence of fibrosis stages should be taken into account when interpreting the studies that validated this method using liver biopsy as a gold-standard. LSM might be influenced by nonfasting status, flare of transaminases, heart failure, extrahepatic cholestasis, presence of steatosis, aetiology of liver disease, type and position of probe, and operator's experience. In addition, interobserver variability can impact on the management of patients with chronic liver diseases. TE should be performed by an experienced operator (>100 exams), in a 3-hour fasting status, and its results should be handled by specialist clinicians that are aware of the limitations of this method.
Similar articles
-
Inflammatory activity affects the accuracy of liver stiffness measurement by transient elastography but not by two-dimensional shear wave elastography in non-alcoholic fatty liver disease.Liver Int. 2022 Jan;42(1):102-111. doi: 10.1111/liv.15116. Epub 2021 Dec 3. Liver Int. 2022. PMID: 34821035 Free PMC article.
-
Ultrasound Shear Wave Elastography for Liver Disease. A Critical Appraisal of the Many Actors on the Stage.Ultraschall Med. 2016 Feb;37(1):1-5. doi: 10.1055/s-0035-1567037. Epub 2016 Feb 12. Ultraschall Med. 2016. PMID: 26871407
-
Update of liver fibrosis and steatosis with transient elastography (Fibroscan).Gastroenterol Rep (Oxf). 2013 Jul;1(1):19-26. doi: 10.1093/gastro/got007. Epub 2013 Mar 26. Gastroenterol Rep (Oxf). 2013. PMID: 24759663 Free PMC article.
-
Transient elastography for diagnosis of stages of hepatic fibrosis and cirrhosis in people with alcoholic liver disease.Cochrane Database Syst Rev. 2015 Jan 22;1(1):CD010542. doi: 10.1002/14651858.CD010542.pub2. Cochrane Database Syst Rev. 2015. PMID: 25612182 Free PMC article. Review.
-
Transient Elastography and Controlled Attenuation Parameter for Diagnosing Liver Fibrosis and Steatosis in Ontario: An Economic Analysis.Ont Health Technol Assess Ser. 2015 Nov 1;15(19):1-58. eCollection 2015. Ont Health Technol Assess Ser. 2015. PMID: 26664666 Free PMC article. Review.
Cited by
-
Metabolic fingerprint of progression of chronic hepatitis B: changes in the metabolome and novel diagnostic possibilities.Metabolomics. 2021 Jan 25;17(2):16. doi: 10.1007/s11306-020-01767-y. Metabolomics. 2021. PMID: 33495863
-
Real-world single-center experience with direct-acting antivirals for improvement of the liver fibrosis after chronic hepatitis C treatment.Antivir Chem Chemother. 2020 Jan-Dec;28:2040206620974835. doi: 10.1177/2040206620974835. Antivir Chem Chemother. 2020. PMID: 33215505 Free PMC article.
-
FibroMeter scores are predictive noninvasive markers of advanced and significant liver fibrosis in patients with chronic viral hepatitis or metabolic dysfunction-associated steatotic liver disease.Ann Gastroenterol. 2023 Nov-Dec;36(6):661-669. doi: 10.20524/aog.2023.0841. Epub 2023 Nov 3. Ann Gastroenterol. 2023. PMID: 38023979 Free PMC article.
-
Noninvasive scores for the prediction of esophageal varices and risk stratification in patients with cirrhosis.World J Hepatol. 2020 Nov 27;12(11):908-918. doi: 10.4254/wjh.v12.i11.908. World J Hepatol. 2020. PMID: 33312418 Free PMC article. Review.
-
Significant liver fibrosis assessed using liver transient elastography is independently associated with low bone mineral density in patients with non-alcoholic fatty liver disease.PLoS One. 2017 Jul 31;12(7):e0182202. doi: 10.1371/journal.pone.0182202. eCollection 2017. PLoS One. 2017. PMID: 28759632 Free PMC article.
References
-
- Singh S., Fujii L. L., Murad M. H., et al. Liver stiffness is associated with risk of decompensation, liver cancer, and death in patients with chronic liver diseases: a systematic review and meta-analysis. Clinical Gastroenterology and Hepatology. 2013;11(12):1573–1584. doi: 10.1016/j.cgh.2013.07.034. - DOI - PMC - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources